In human breast cancer, the expression of FGFR2 has long been known to be elevated in estrogen receptor (ER)–positive tumours [4], which has been confirmed by data analysis performed with the ONCOMINE 3.0 array database [5,6]. This evidence concerns the gene FGFR2 and neoplasm.